A detailed history of Invesco Ltd. transactions in Novo Nordisk A S stock. As of the latest transaction made, Invesco Ltd. holds 520,452 shares of NVO stock, worth $45.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
520,452
Previous 821,141 36.62%
Holding current value
$45.5 Million
Previous $117 Million 47.13%
% of portfolio
0.01%
Previous 0.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $35.8 Million - $43.7 Million
-300,689 Reduced 36.62%
520,452 $62 Million
Q2 2024

Aug 13, 2024

SELL
$122.71 - $146.91 $3.99 Million - $4.78 Million
-32,512 Reduced 3.81%
821,141 $117 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $9.92 Million - $13.2 Million
97,147 Added 12.84%
853,653 $110 Million
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $16 Million - $19.2 Million
181,839 Added 31.64%
756,506 $78.3 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $26.1 Million - $57.3 Million
287,308 Added 99.98%
574,667 $52.3 Million
Q2 2023

Aug 11, 2023

BUY
$155.98 - $172.65 $10.2 Million - $11.3 Million
65,674 Added 29.62%
287,359 $46.5 Million
Q1 2023

May 12, 2023

BUY
$132.34 - $159.14 $4.72 Million - $5.67 Million
35,651 Added 19.16%
221,685 $35.3 Million
Q4 2022

Feb 13, 2023

SELL
$102.55 - $135.33 $2.76 Million - $3.64 Million
-26,870 Reduced 12.62%
186,034 $25.2 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $6.89 Million - $8.46 Million
-72,314 Reduced 25.35%
212,904 $21.2 Million
Q2 2022

Aug 15, 2022

SELL
$103.24 - $121.81 $46.3 Million - $54.6 Million
-448,361 Reduced 61.12%
285,218 $31.8 Million
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $28.4 Million - $34.4 Million
305,338 Added 71.3%
733,579 $81.5 Million
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $11.5 Million - $14 Million
119,654 Added 38.77%
428,241 $48 Million
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $1.2 Million - $1.52 Million
-14,243 Reduced 4.41%
308,587 $29.6 Million
Q2 2021

Aug 17, 2021

SELL
$67.66 - $84.76 $397,096 - $497,456
-5,869 Reduced 1.79%
322,830 $27 Million
Q1 2021

May 17, 2021

SELL
$67.06 - $75.82 $804,183 - $909,233
-11,992 Reduced 3.52%
328,699 $22.2 Million
Q4 2020

Feb 16, 2021

SELL
$63.89 - $73.8 $939,310 - $1.09 Million
-14,702 Reduced 4.14%
340,691 $23.8 Million
Q3 2020

Nov 16, 2020

BUY
$63.69 - $70.22 $6.44 Million - $7.1 Million
101,139 Added 39.78%
355,393 $24.7 Million
Q2 2020

Aug 14, 2020

BUY
$58.54 - $67.94 $5.53 Million - $6.41 Million
94,419 Added 59.07%
254,254 $16.6 Million
Q1 2020

May 15, 2020

BUY
$49.46 - $64.78 $3.14 Million - $4.11 Million
63,437 Added 65.81%
159,835 $9.62 Million
Q4 2019

Feb 14, 2020

SELL
$49.86 - $58.26 $1.07 Million - $1.25 Million
-21,400 Reduced 18.17%
96,398 $5.58 Million
Q3 2019

Nov 14, 2019

SELL
$47.54 - $53.43 $1.24 Million - $1.39 Million
-26,033 Reduced 18.1%
117,798 $6.09 Million
Q2 2019

Aug 14, 2019

SELL
$46.79 - $52.47 $798,518 - $895,453
-17,066 Reduced 10.61%
143,831 $7.34 Million
Q1 2019

May 15, 2019

SELL
$46.36 - $52.63 $1.42 Million - $1.61 Million
-30,663 Reduced 16.01%
160,897 $8.42 Million
Q4 2018

Feb 14, 2019

BUY
$41.54 - $47.25 $7.96 Million - $9.05 Million
191,560 New
191,560 $8.83 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.